Biogen Says EU Committee Issues Positive View on FLIXABI to Treat Rheumatoid …

Biogen Says EU Committee Issues Positive View on FLIXABI to Treat Rheumatoid …

Biogen's (NASDAQ:BIIB) FLIXABI shares were practically unchanged on Friday after the European Medicines Agency's Committee for Medicinal Products for Human Use issued a positive opinion for the marketing authorization of FLIXABI for adults suffering …

(Visited 1 times, 1 visits today)
1
Like
Save

Comments

Write a comment

*